| HORIZON | TRADES | WIN RATE | INSIDER RETURN | SPY RETURN | MEAN EXCESS | MEDIAN EXCESS | T-STAT |
|---|---|---|---|---|---|---|---|
| 7d | 19 | +68.42% | -2.51% | -1.07% | -1.44% | -5.09% | — |
| 14d | 19 | +68.42% | -0.20% | -1.53% | +1.33% | -2.16% | — |
| 30d | 19 | +63.16% | +5.82% | +0.88% | +4.94% | +0.56% | — |
| 60d | 19 | +73.68% | +4.74% | +3.77% | +0.97% | +8.09% | — |
| 90d | 19(1 pending) | +77.78% | +4.21% | +7.76% | -4.30% | -9.19% | — |
| 180d | 19(3 pending) | +93.75% | +10.35% | +14.55% | -4.20% | +1.39% | — |
| 1y | 19(3 pending) | +87.50% | +64.82% | +25.19% | +39.63% | +29.05% | — |
| 2y | 19(5 pending) | +78.57% | +2.87% | +36.77% | -33.90% | -36.82% | — |
| COMPANY | TYPE | SHARES | PRICE | VALUE | HELD AFTER | TRADE DATE | FILED | DETAILS |
|---|---|---|---|---|---|---|---|---|
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE President and CEO | 233,532 | — | — | 286,650 | Apr 29, 2026 | Apr 30, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE President and CEO | 233,532 | — | — | 714,613 | Apr 29, 2026 | Apr 30, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 72,559 | $9.16 | $664.4K | 948,145 | Apr 6, 2026 | Apr 7, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 14,762 | $9.53 | $140.7K | 1,020,704 | Feb 24, 2026 | Feb 26, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 19,039 | $7.45 | $141.9K | 1,035,466 | Feb 23, 2026 | Feb 24, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 285,000 | — | — | 1,054,505 | Feb 22, 2026 | Feb 24, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 570,000 | — | — | 570,000 | Feb 22, 2026 | Feb 24, 2026 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 79,712 | $5.95 | $474.2K | 769,505 | Apr 3, 2025 | Apr 4, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 16,122 | $9.45 | $152.4K | 849,217 | Feb 24, 2025 | Feb 25, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 480,000 | — | — | 480,000 | Feb 22, 2025 | Feb 25, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 240,000 | — | — | 865,339 | Feb 22, 2025 | Feb 25, 2025 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE Chief Executive Officer | 53,118 | — | — | 625,339 | Jun 12, 2024 | Jun 12, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASE Chief Executive Officer | 53,118 | — | — | 53,118 | Jun 12, 2024 | Jun 12, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | SALE10b5-1 10b5-1 plan | 72,995 | $9.46 | $690.4K | 678,457 | Apr 3, 2024 | Apr 4, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 175,000 | — | — | 751,452 | Feb 22, 2024 | Feb 26, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 350,000 | — | — | 350,000 | Feb 22, 2024 | Feb 26, 2024 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 576,452 | — | — | 576,452 | Apr 3, 2023 | Apr 4, 2023 ↗ | View → |
| VIR VIR BIOTECHNOLOGY, INC. | PURCHASEGRANT Stock grant | 1,152,904 | — | — | 1,152,904 | Apr 3, 2023 | Apr 4, 2023 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 7,867 | — | — | 31,267 | Jan 10, 2023 | Jan 11, 2023 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 4,593 | — | — | 4,593 | Jan 10, 2023 | Jan 11, 2023 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 6,400 | — | — | 23,400 | Jan 7, 2022 | Jan 7, 2022 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE | 272 | $66.25 | $18.0K | 17,000 | Jan 3, 2022 | Jan 4, 2022 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE | 2,244 | $64.25 | $144.2K | 19,256 | Jan 3, 2022 | Jan 4, 2022 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE | 1,984 | $65.01 | $129.0K | 17,272 | Jan 3, 2022 | Jan 4, 2022 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | SALE | 5,000 | $89.85 | $449.3K | 21,500 | Jun 24, 2021 | Jun 25, 2021 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 9,000 | — | — | 26,500 | Jan 1, 2021 | Jan 5, 2021 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $50.93 | $25.5K | 17,000 | Oct 8, 2020 | Oct 26, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $50.00 | $25.0K | 17,500 | Oct 8, 2020 | Oct 26, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $31.33 | $15.7K | 16,500 | Jun 15, 2020 | Jun 24, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $35.40 | $17.7K | 16,000 | Apr 15, 2020 | Jun 24, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $23.94 | $12.0K | 15,500 | Mar 16, 2020 | Jun 24, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $24.80 | $12.4K | 15,000 | Mar 12, 2020 | Jun 24, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $28.60 | $14.3K | 14,500 | Mar 11, 2020 | Jun 24, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $34.39 | $17.2K | 14,000 | Feb 28, 2020 | Jun 24, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $35.07 | $17.5K | 13,500 | Feb 27, 2020 | Jun 24, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASE | 500 | $54.95 | $27.5K | 13,000 | Jan 13, 2020 | Jun 24, 2020 ↗ | View → |
| ARWR ARROWHEAD PHARMACEUTICALS, INC. | PURCHASEGRANT Stock grant | 7,500 | — | — | 12,500 | Jan 1, 2020 | Jan 3, 2020 ↗ | View → |